| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |